Latest Insights - page 61 | BiopharmaTrend

Advarra Centralizes Clinical Trial Patient Recruitment to Enhance Enrollment Efficiency

Advarra has introduced new functionality to centralize patient recruitment activities within its Longboat platform. This enhancement aims to provide sponsors and contract research organizations (CROs) with a comprehensive view of …

Continue ›››

Insilico Medicine Unveils AI Assistant for Medical Research Drafting

On a press webinar today, Insilico Medicine, known for its advancements in AI-driven drug discovery, has announced updates to its Pharma.AI platform and unveiled a new AI assistant, DORA, designed …

Continue ›››

Touchlight and GSK Partner for Enzymatic dbDNA Production in mRNA Manufacturing

Touchlight, a contract development and manufacturing organization (CDMO) specializing in enzymatic DNA production, has entered into a licensing agreement with GSK, a prominent biopharmaceutical company. This collaboration grants GSK non-exclusive …

Continue ›››

The Synergistic Potential of AI and Synthetic Biology: Interview with S&P Global’s Miriam Fernández

The rapid convergence of artificial intelligence (AI) and synthetic biology (synbio) is set to revolutionize a multitude of industries, ranging from healthcare and agriculture to renewable energy and environmental remediation. …

Continue ›››

Abiologics Emerges to Introduce New Class of Biologic Drugs

Flagship Pioneering, a bioplatform innovation company, has announced the launch of Abiologics, a new venture focused on revolutionizing the field of biologics through the creation of Synteins™, a new class …

Continue ›››

Proscia Introduces Enhanced Concentriq AP with Multi-AI Workflows for Pathology

Proscia, a provider of AI-powered pathology solutions for precision medicine, has announced an update to its Concentriq AP platform. The latest version introduces multi-AI workflows, enabling pathologists to simultaneously view …

Continue ›››

New Insurance Model Could Transform Clinical Trial Financing

A novel initiative by Medical and Commercial International Limited (MCI) and GATC Health Corp, supported by Lloyd's of London, promises to improve clinical trial funding through innovative insurance coverage.

Continue ›››

Biotech Trends to Watch: Reflecting on the First Half of 2024

If we talk about tech advances in pharma and biotech, the year 2024 has been a blast so far! Last December I compiled a list of 11 Biopharma Trends to …

Continue ›››

New Liquid Biopsy Method Enables Monitoring of Disease Evolution in Metastatic Prostate Cancer Patients

A new liquid biopsy approach enables monitoring of disease evolution in patients with metastatic prostate cancer through the analysis of extracellular vesicles (EVs) in the bloodstream. These vesicles, which contain …

Continue ›››

10 Notable Biotech Companies With Recent Major VC Rounds

As the biotech sector recovers to pre-COVID investment levels, venture capital firms have become more selective in their funding choices. In 2024, private U.S. drug companies raised $3.8 billion in …

Continue ›››

Accidental Breakthrough in Aging Research

Recent research reveals that blocking an inflammation-promoting protein, IL-11, can significantly extend the lifespan and improve the health of laboratory mice. This finding, detailed in a study published in Nature …

Continue ›››

Artiva Biotherapeutics Lowers IPO Price, Raises $167 Million for Autoimmune Therapies

Artiva Biotherapeutics, a clinical-stage biotechnology company, has raised $167 million through its initial public offering (IPO). The company offered 13.9 million shares at $12 each, below the anticipated range of …

Continue ›››